医软信息科技(上海)有限公司
EDDA Technology (医软信息科技上海) develops the IQQA® platform for AI-driven 3D medical imaging analysis, surgical navigation robots, and precision cancer surgery planning, serving over 100 tier-3 hospitals globally across China, the US, Southeast Asia, and the Middle East.
- Company typePrivate
- Founded2004
- HeadquartersShanghai, China
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What 医软信息科技(上海)有限公司 does
EDDA Technology, operating through its Chinese subsidiary 医软信息科技(上海)有限公司 (founded 2004 in the Shanghai Pilot Free Trade Zone) and affiliated US parent EDDA Technology, Inc. (Delaware-incorporated, headquartered in Princeton, NJ), develops and commercializes the IQQA® platform — a proprietary real-time interactive, fully quantitative 3D medical imaging analysis system. The platform comprises IQQA-Guide (intelligent puncture/needle navigation robotic system), IQQA-3D (organ-specific 3D imaging analysis modules for liver, lung, kidney, and interventional applications), IQQA-eQMR (quantitative mixed reality visualization), and IQQA-Chest CAD (lung nodule computer-aided detection). IQQA products have obtained NMPA, FDA, and CE regulatory approvals and combine computer vision, 3D reconstruction, quantitative analysis, intraoperative navigation, and mixed reality to cover the full disease management cycle — early detection, pre-operative planning, intra-operative guidance, and post-operative evaluation — for cancer care, particularly liver, lung, pancreatic, kidney, and other solid-organ tumors. The IQQA-Guide device is classified by China's NMPA as the country's first puncture surgical navigation system for adult lung and abdominal soft-tissue solid organs.
The company monetizes through four revenue streams: (1) one-time enterprise licenses for IQQA-3D installations in tier-3 hospitals, including named reference accounts such as Mayo Clinic, Massachusetts General Hospital, Beijing 301 Hospital, Peking Union Medical College Hospital, Huaxi Hospital, and Ruijin Hospital (over 100 hospitals cumulatively across China, the US, the Middle East, and Southeast Asia); (2) subscription-based cloud services via the IQQA cloud platform supporting remote pre/post-operative evaluation and multi-disciplinary team collaboration; (3) OEM/embedded licensing royalties through channel partnerships with Philips (since 2006) and Shimadzu (since 2009), bundling IQQA-Chest with their digital radiography and X-ray imaging systems globally; and (4) professional services including installation, training, expert consultation, and 3D printing. Over 75,000 clinical cases have been performed using the IQQA platform and more than 550 peer-reviewed publications have validated clinical utility.
EDDA's corporate structure includes 医软信息科技(上海)有限公司 (Shanghai HQ entity, 2004), 医达极星医疗科技(苏州)有限公司 (Suzhou subsidiary at the national medical device industrial base, 2015), and the US parent EDDA Technology, Inc. The company employs a hybrid go-to-market combining direct enterprise sales to top tier-3 hospitals, OEM channel distribution via Philips and Shimadzu, and a cloud-based self-service model extending reach to grassroots and remote hospitals. Founder, Chairman and CEO Dr. Qian Jianzhong is an AIMBE Fellow and former Siemens principal research scientist with 200+ patents in intelligent medical diagnostic imaging. In April 2021, EDDA completed a $150 million strategic financing round led by SoftBank Vision Fund with OrbiMed participation to scale intelligent surgical robotics and precision surgery solutions globally.
医软信息科技(上海)有限公司 firmographics
Firmographics- Name
- 医软信息科技(上海)有限公司
- Legal name
- 医软信息科技(上海)有限公司
- Website
- https://eddatech.com.cn
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- EDDA Technology (医软信息科技上海) develops the IQQA® platform for AI-driven 3D medical imaging analysis, surgical navigation robots, and precision cancer surgery planning, serving over 100 tier-3 hospitals globally across China, the US, Southeast Asia, and the Middle East.
- Ownership category
- akta.pro rank
医软信息科技(上海)有限公司 industry classification
Industry- Product category
- Medical Imaging and Surgical Navigation Software
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Surgical and Medical Instrument Manufacturing (339112), Diagnostic Imaging Centers (621512)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro industry
- Surgical Robotics & Computer-Assisted Surgery PlatformsHealthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR EquipmentRadiology AI, CAD & Advanced Visualization SoftwareSurgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR EquipmentIntraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR EquipmentMedical Imaging AIHardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Computer Vision & Video Analytics
Keywords
Where 医软信息科技(上海)有限公司 is headquartered
LocationHeadquarters
- HQ city
- Shanghai
- HQ country
- China
- HQ region
- Asia
Offices3 records
Markets served
医软信息科技(上海)有限公司 business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- 医疗软件产品销售 (IQQA®-3D系列): 向医院销售IQQA®-3D影像解读分析系统(IQQA®-Guide穿刺手术导航设备、IQQA®-3D肝胆/胸肺/泌尿/介入系统、IQQA®-Chest CAD等),产品已获NMPA/FDA/CE认证,在国内外医院装机使用。
- IQQA®云服务技术平台: 提供IQQA®影像精准计算机分析云服务,支持远程术前评估、手术规划及异地专家协同会诊,并提供线上线下的技术和后勤服务(如专家咨询、医联体转诊、3D打印建模服务等)。
- OEM/嵌入式软件授权 (Philips/岛津合作): 向Philips、岛津等国际医疗设备厂商授权,将IQQA®-Chest CAD与对方的数字放射影像系统产品整合后全球销售EDDA科技收取授权费。
- 专业服务与培训: 为医院客户提供产品安装、培训、售后技术支持等服务,并提供医联体转诊服务、医生专家咨询对接等增值服务。
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
医软信息科技(上海)有限公司 product offering
Product offeringCore offering
医软信息科技(上海)有限公司 develops, manufactures, and sells the IQQA® intelligent surgery robot and precision surgery solution platform for medical imaging analysis. Its products span the full clinical cycle — from early cancer detection and quantitative diagnosis, to patient-specific 3D surgical planning and simulation, intraoperative real-time image-guided navigation, and postoperative evaluation. The portfolio includes the IQQA®-Guide puncture surgical navigation robot, the IQQA®-3D organ-specific imaging analysis systems (liver, lung, kidney, interventional), IQQA®-Chest CAD for chest X-ray aided diagnosis, IQQA®-eQMR quantitative mixed reality system, and the IQQA® cloud service platform, all marketed to large tertiary hospitals worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- IQQA®: Proprietary technology platform and product brand for intelligent surgery robots and precision surgery solutions, including IQQA®-Guide navigation system, IQQA®-3D imaging analysis systems, IQQA®-eQMR quantitative mixed reality system, and IQQA®-Chest CAD.
Products and services
- IQQA®-Guide Puncture Surgical Navigation Device (IQQA®-Guide穿刺手术导航设备) A next-generation intelligent intraoperative navigation robot built on the IQQA® personalized 3D fully-quantitative organ electronic map. It brings real-time interactive quantitative imaging into surgery, minimally invasive intervention, and robotic procedures — intelligently tracking surgical targets with full 3D quantitative image positioning, tracking, guidance, and monitoring throughout the operation. Indicated for puncture procedures on adult lung and abdominal soft tissue solid organs; improves puncture accuracy and reduces needle passes and CT scans compared with conventional CT-guided approaches. For tertiary, grassroots, and remote hospitals performing thoracic and abdominal tumor minimally invasive interventions.
- IQQA®-3D Imaging Analysis System (IQQA®-3D, including Liver, Lung, Kidney, and Interventional editions) An NMPA-approved, FDA-cleared (as IQQA®-Liver and others) series of 3D quantitative image analysis products installed in hospitals for clinicians to use directly. Provides real-time interactive, intelligent, fully-quantitative 3D analysis of thoracic and abdominal CT or MR images for organs including liver, lung, pancreas, bile duct, kidney, and vasculature. Used for preoperative and postoperative evaluation in liver surgery, biliary-pancreatic surgery, thoracic-pulmonary surgery, urology, and oncological interventional surgery, as well as intraoperative quantitative monitoring of percutaneous minimally invasive interventions. Sub-editions include IQQA®-3D Liver (IQQA®-3D肝胆), IQQA®-3D Lung (IQQA®-3D胸肺), IQQA®-3D Kidney (IQQA®-3D泌尿), and IQQA®-3D Interventional (IQQA®-3D介入).
- IQQA®-eQMR Quantitative Mixed Reality System (IQQA®-eQMR全定量现实虚拟系统) Combines the fully-quantitative virtual patient anatomy reconstructed from CT/MR data with the real world, displayed via holographic imagery, with support for gesture and voice commands for real-time interactive quantitative analysis. Used for precision preoperative evaluation, virtual surgical simulation, and surgical risk assessment. Available in clinical and teaching editions; supports clinical teaching and doctor-patient communication.
- IQQA®-Chest CAD Digital Medical Imaging Aided Diagnosis Software (IQQA®-Chest CAD) Chest digital X-ray computer-aided detection and diagnosis software using internationally patented innovative technology to assist physicians in early detection of pulmonary nodules (5-15mm). Reported improvement of pulmonary nodule detection rate from 63.8% to 92.7%. NMPA, FDA, and CE certified. Licensed to Philips for integration with its digital radiography systems and to Shimadzu for combination with its digital X-ray systems for global resale.
- IQQA® Cloud Service Platform (IQQA®影像精准计算机分析云服务技术平台) A cloud-based image quantitative analysis platform built on the NMPA/FDA-cleared IQQA®-3D technology. Enables physicians to perform precision preoperative and postoperative evaluation and surgical planning from any location at any time using patient CT/MR data, and supports multi-disciplinary team (MDT) remote collaboration and consultation across geographies. Includes online and offline technical and logistics services such as expert physician consultation, hospital referral (医联体转诊), and 3D printing modeling for confirmed surgical plans.
Quantifiable outcome
- 使用IQQA®-Chest CAD可将肺小结节(5-15mm)检出率从63.8%提高至92.7%
- +4 more outcomes
Companies that use 医软信息科技(上海)有限公司
Customer profileNamed customers16 records
Segments4 records
Ideal customer profiles3 records
医软信息科技(上海)有限公司 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability4 records
Feature7 records
医软信息科技(上海)有限公司 partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered 重要渠道合作伙伴, 重要医工合作 and 医联体合作.
- 岛津公司 (Shimadzu Corporation)重要渠道合作伙伴岛津公司与EDDA科技就数字X光胸部CAD技术应用结成商业合作伙伴关系,岛津授权结合其直转式平板探测器(FPD)数字X射线成像系统,通过岛津全球销售渠道销售IQQA®-Chest CAD系统,并联合开发新型胸部CAD应用技术。
- Philips (皇家飞利浦电子公司)重要渠道合作伙伴Philips与EDDA科技结成战略伙伴,授权Philips销售IQQA®-Chest(肺部数字医学图像辅助诊断软件),结合Philips数字放射系统产品组合向用户提供软硬件整合解决方案,是第一个实时交互诊断分析系统与数字放射影像产品的深度整合。产品首先在美国和中国市场投放。
- 清华大学医学院重要医工合作清华大学医学院与EDDA科技共建"智慧现实虚拟临床教学中心",开创人工智能辅助临床教学新模式。董家鸿院士(清华大学附属北京清华长庚医院院长)与EDDA科技开展深度医工合作,共同推动精准外科理念落地。
- 拉萨市人民医院医联体合作2020年11月,"拉萨市人民医院-EDDA精准外科手术合作中心"正式启动,共建医联互通,将IQQA智能云平台引入世界屋脊(青藏高原),造福藏区同胞,使优质医疗资源有效下沉基层。
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
医软信息科技(上海)有限公司 competitors and assessment
Company assessmentDirect peers
- Intuitive Surgical: Global leader in surgical robotics with the da Vinci platform spanning urology, gynecology, and general surgery. Direct competitor in computer-assisted surgery and navigation, though EDDA focuses on image-guided puncture navigation rather than full laparoscopic platforms.
- Brainlab: Munich-based developer of software-driven surgical planning, navigation, and augmented-reality guidance for neurosurgery, spine, ENT, and cranio-maxillofacial procedures. Closely comparable on surgical navigation software and IQQA®'s core image-guided quantitative analysis approach.
Emerging players
- HeartFlow: AI-driven non-invasive cardiac imaging analysis (FFR-CT) provider with cloud-based analytics. Comparable on the AI + cloud + clinical-decision-support model applied to high-impact imaging, though focused exclusively on coronary disease.
- 7D Surgical: Canadian machine-vision surgical navigation company with FDA-cleared spine and cranial platforms. Comparable on image-based surgical navigation but narrower in clinical scope than EDDA's multi-organ IQQA®-Guide and 3D systems.
Broad incumbents
- Siemens Healthineers: Imaging modality leader (CT, MR, X-ray) with growing AI-Rad Companion and digital health portfolio. Overlaps with EDDA on AI-driven radiology workflow, surgical planning, and cloud-enabled imaging analytics across hospital networks.
- Olympus: Endoscopy and surgical visualization incumbent expanding into AI-enabled image analysis and computer-assisted intervention. Adjacent overlap with EDDA on image-guided minimally invasive surgery and hospital channel presence.
- Stryker (Mako Surgical / Navigation): Orthopedic surgical robotics leader with the Mako platform and an active surgical navigation business. Overlaps with EDDA on image-guided surgical planning and computer-assisted intervention, particularly in oncology-adjacent procedures.
- Philips: Global imaging OEM and EDDA's primary Chest CAD channel partner since 2006. Competes broadly in radiology imaging, AI-enabled diagnostics, and image-guided therapy, providing both a go-to-market route and a competitive threat if Philips develops native AI capabilities.
- GE HealthCare: Imaging equipment and Edison AI platform provider serving large hospital systems worldwide. Direct adjacency through imaging AI, surgical planning software, and OEM-bundled AI applications that compete for the same hospital budgets as IQQA®.
- Medtronic (Hugo RAS / Surgical Innovations): Diversified medical device incumbent with the Hugo robotic-assisted surgery platform plus broad surgical navigation portfolio. Competes across the full surgical robotics and image-guided surgery stack, with substantially larger R&D and commercial resources.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
医软信息科技(上海)有限公司 social profiles
Digital presence医软信息科技(上海)有限公司 financial estimates
Financial estimateRevenue estimate
Valuation estimate
医软信息科技(上海)有限公司 leadership team
Management profileNumber of profiles
Profiles1 record
医软信息科技(上海)有限公司 subsidiaries and ownership
Company hierarchySubsidiaries2 records
医软信息科技(上海)有限公司 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
医软信息科技(上海)有限公司 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 医软信息科技(上海)有限公司
What does 医软信息科技(上海)有限公司 do?
医软信息科技(上海)有限公司 develops, manufactures, and sells the IQQA® intelligent surgery robot and precision surgery solution platform for medical imaging analysis. Its products span the full clinical cycle — from early cancer detection and quantitative diagnosis, to patient-specific 3D surgical planning and simulation, intraoperative real-time image-guided navigation, and postoperative evaluation. The portfolio includes the IQQA®-Guide puncture surgical navigation robot, the IQQA®-3D organ-specific imaging analysis systems (liver, lung, kidney, interventional), IQQA®-Chest CAD for chest X-ray aided diagnosis, IQQA®-eQMR quantitative mixed reality system, and the IQQA® cloud service platform, all marketed to large tertiary hospitals worldwide.
Is 医软信息科技(上海)有限公司 a public or private company?
医软信息科技(上海)有限公司 is a private company. It is classified as venture growth investor backed and is currently operating.
When was 医软信息科技(上海)有限公司 founded?
医软信息科技(上海)有限公司 was founded in 2004. It employs 1 to 10 people.
Where is 医软信息科技(上海)有限公司 based?
医软信息科技(上海)有限公司 is headquartered in Shanghai, China, in the Asia region.
How does 医软信息科技(上海)有限公司 make money?
Four revenue lines are on record. 医疗软件产品销售 (IQQA®-3D系列) is the primary driver. The others are IQQA®云服务技术平台, OEM/嵌入式软件授权 (Philips/岛津合作) and 专业服务与培训.
Who are 医软信息科技(上海)有限公司's main competitors?
Direct peers on record are Intuitive Surgical and Brainlab. Emerging players are HeartFlow and 7D Surgical. Broad incumbents are Siemens Healthineers, Olympus, Stryker (Mako Surgical / Navigation), Philips, GE HealthCare and Medtronic (Hugo RAS / Surgical Innovations).
Does 医软信息科技(上海)有限公司 have an API?
No public API is recorded for 医软信息科技(上海)有限公司.
What industry is 医软信息科技(上海)有限公司 in?
医软信息科技(上海)有限公司's product category is Medical Imaging and Surgical Navigation Software. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 33451 and its SIC code is 3841.